https://www.selleckchem.com/pr....oducts/nuciferine.ht
69-0.84]. Hosmer-Leme show test indicated that the model had good goodness of fit (P=0.83). The decision curve revealed this a nomogram model was feasible in clinical practice. In our clinical cohort, the calibration curve did not show good calibration and discrimination. We established a nomogram model, including the mutation status of , , and ; pathological location; and preoperative CEA value, which showed accuracy in the risk prediction of stage III/IV CRC patients. We established a nomogram model, including the mutation status o
Like
Comment
Share
